Want to see SKIN full AI Analyst Report?
SKIN Stock Chart & Stats
$0.68
$0.06(7.89%)
At close: 4:00 PM EDT
$0.68
$0.06(7.89%)
Day’s Range― - ―
52-Week Range$9.89 - $34.80
Previous CloseN/A
Volume298.38K
Average Volume (3M)30.11K
Market Cap
$66.05M
Enterprise Value$250.71M
Total Cash (Recent Filing)$206.10M
Total Debt (Recent Filing)$367.10M
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Nov 05, 2026EPS Estimate
-1.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.51
Shares Outstanding6,507,038
10 Day Avg. Volume54,070
30 Day Avg. Volume30,107
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)2.88
Price to Sales (P/S)0.58
P/FCF Ratio5.43
Enterprise Value/Market Cap3.80
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit1.30
Enterprise Value/Ebitda9.64
Forecast
1Y Price Target
$12.50Price Target Upside1738.24% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)-3.17
Revenue Forecast (FY)$284.80M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue BaseThe growing installed base expands the number of providers able to generate repeat consumables demand, while the 75% recurring mix improves revenue visibility. This platform economics can support customer retention, monetization of utilization, and more durable revenue than equipment sales alone.
Margin And EBITDA ImprovementMaterial gross-margin expansion and adjusted EBITDA above guidance indicate that operational efficiencies, lower equipment costs, and consumables mix are improving earnings conversion. If sustained, stronger unit economics could provide financial capacity for product investment and support future operating leverage.
Convertible Debt RetirementRetiring the 2026 convertible notes removes a significant near-term maturity and associated covenants, while also eliminating conversion-related dilution from that instrument. The action should simplify the capital structure and improve financial flexibility as management executes its operating plans.
Bears Say
Revenue ContractionTop-line contraction across geographies and product lines indicates that the recovery remains incomplete, while the reduced annual outlook lowers the near-term scale available to absorb fixed costs. Persistent revenue pressure could delay a return to durable profitability and constrain investment flexibility.
Equipment And Consumables WeaknessWeakness in both system placements and consumables suggests pressure on provider capital spending and treatment utilization, affecting both upfront revenue and the recurring monetization engine. Lower utilization can also make installed-base growth less valuable if providers struggle to retain patient frequency.
High Leverage And Ongoing LossesAlthough debt has declined from prior peaks, leverage remains aggressive relative to the thin equity base, leaving limited cushion if operating performance weakens. Continued net losses reduce internally generated capital and can restrict the company’s ability to fund growth, absorb volatility, or reduce obligations.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $9.89 and its highest was $34.80 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $66.05M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Nov 05, 2026 which is in 5 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on Aug 06, 2026. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.5 by $0.1.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -1.34.
How many shares outstanding does Beauty Health have?
Beauty Health has 6,507,038 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.5. Following the earnings report the stock price went down -13.904%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.50 (1738.24% Upside)
$12.50 (1738.24% Upside)
Blogger Sentiment
Neutral
SKIN Sentiment 50%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 167.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.00%
12-Months-Change
Fundamentals
Return on Equity
-47.84%
Trailing 12-Months
Asset Growth
-4.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Beauty Health
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Company Deck
SKIN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: strong margin improvement, adjusted EBITDA upside and tangible strategic progress (rental program, product pipeline, installed‑base monetization) are positive. However, meaningful top‑line weakness — driven by an 18.4% decline in equipment revenue, continued consumables softness, regional softness in EMEA, and near‑term balance sheet and Nasdaq listing risks — tempers the outlook. Management is focused on execution and long‑term investments, but near‑term revenue and capital markets pressures balance the positives.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$12.50
▲(1738.24% Upside)
Technical Analysis
Ownership Overview
7.70% Insiders
11.07% Mutual Funds
0.19% Other Institutional Investors
78.42% Public Companies and
Individual Investors